Drugs / tirzepitide
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06132477 Comparator | Feb 2024 → Jul 2028 expected | abdominal obesity-metabolic syndrome, diabetes mellitus, hypertensive disorder, morbid obesity +1 | University of Missouri-Columbia | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tirzepitide | “This includes semaglutide, tirzepitide, among others.” NCT06132477 ↗ |